MENUCLOSE

 

Connect with us

Category : Clinical Research Blog

Our Collective Response to COVID-19

We are all finding ways personally and professionally to meet the challenge posed by COVID-19.  Earlier this month, as the threat of COVID-19 was becoming increasingly clear, we at ArcheMedX took decisive action to protect our employees, their families, and our business partners by freezing all travel, ensuring we could work

Interview: One ClinOps Leader Tells His Story on Site Preparedness, and Offers the Industry Some Advice

We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based in Morrisville, North Carolina, that focuses on identifying, developing, and commercializing products to address cardiovascular and pulmonary diseases. We wanted to share these excerpts from the conversation:  ArcheMedX:  You’ve talked about the importance of telling your story. Can you expound on that?    Crawford:  At Tenax therapeutics, we're

We Can and Must Help #StopTheSpread

The threat of Coronavirus (COVID-19) is real and spreading. The most vulnerable among us (the elderly, immunocomprised individuals, and those with underlying health conditions) are at high risk of suffering from this virus. Public health experts and the CDC are urging more extreme social distancing, yet too many of us

Interview: Managing Studies In A Rapidly Changing Treatment Environment

We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech focused on developing personalized, tumor-targeted immunotherapies. The company is based in Plymouth Meeting, PA. We wanted to share these excerpts from the conversation: ArcheMedX: What are the biggest and/or most common challenges you meet with during the